The future of research into rotavirus vaccine - Benefits of vaccine may outweigh risks for children in developing countries

被引：37

作者：

Weijer, C ^{[1
]}

机构：

[1] Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada

来源：

BRITISH MEDICAL JOURNAL | 2000年 / 321卷 / 7260期

关键词：

D O I：

10.1136/bmj.321.7260.525

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：525 / 526

页数：2

共 15 条

[1]

*ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1

[2] The ethics of clinical research in the Third World [J].

Angell, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (12) :847-849

[3]

[Anonymous], MMWR

[4]

BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705

[5] EVALUATION OF RHESUS ROTAVIRUS MONOVALENT AND TETRAVALENT REASSORTANT VACCINES IN US CHILDREN [J].

BERNSTEIN, DI ;

GLASS, RI ;

RODGERS, G ;

DAVIDSON, BL ;

SACK, DA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (15) :1191-1196

[6] Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries [J].

Bresee, JS ;

Glass, RI ;

Ivanoff, B ;

Gentsch, JR .

VACCINE, 1999, 17 (18) :2207-2222

[7] AZT trials and tribulations [J].

Crouch, RA ;

Arras, JD .

HASTINGS CENTER REPORT, 1998, 28 (06) :26-34

[8] EQUIPOISE AND THE ETHICS OF CLINICAL RESEARCH [J].

FREEDMAN, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (03) :141-145

[9] Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis [J].

Joensuu, J ;

Koskenniemi, E ;

Pang, XL ;

Vesikari, T .

LANCET, 1997, 350 (9086) :1205-1209

[10]

KONNO T, 1978, J MED VIROL, V2, P265, DOI 10.1002/jmv.1890020310

← 1 2 →